We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 2015 Guidance Expected on Social Media, Biosimilars and Quality Metrics
2015 Guidance Expected on Social Media, Biosimilars and Quality Metrics
The FDA this year aims to answer key questions on which quality metrics it will collect from drugmakers, how to develop biosimilars and how to use social media to promote products.